KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Long-Term Investments (2016 - 2024)

Supernus Pharmaceuticals has reported Long-Term Investments over the past 13 years, most recently at $11.7 million for Q1 2024.

  • Quarterly Long-Term Investments fell 78.47% to $11.7 million in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $11.7 million through Mar 2024, down 78.47% year-over-year, with the annual reading at $16.6 million for FY2023, 82.3% down from the prior year.
  • Long-Term Investments was $11.7 million for Q1 2024 at Supernus Pharmaceuticals, down from $16.6 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $534.7 million in Q1 2020 and troughed at $11.7 million in Q1 2024.
  • The 5-year median for Long-Term Investments is $131.9 million (2022), against an average of $215.4 million.
  • Year-over-year, Long-Term Investments grew 24.2% in 2021 and then plummeted 82.3% in 2023.
  • A 5-year view of Long-Term Investments shows it stood at $350.4 million in 2020, then plummeted by 65.99% to $119.2 million in 2021, then decreased by 21.21% to $93.9 million in 2022, then plummeted by 82.3% to $16.6 million in 2023, then decreased by 29.82% to $11.7 million in 2024.
  • Per Business Quant, the three most recent readings for SUPN's Long-Term Investments are $11.7 million (Q1 2024), $16.6 million (Q4 2023), and $25.1 million (Q3 2023).